Article
Mutation-associated fusion cancer genes in solid tumors.
Molecular cancer therapeutics - 1 Jun 2009
Kaye Frederic J
Abstract excerpt
Chromosomal translocations and fusion oncogenes serve as the ultimate biomarker for clinicians as they show specificity for distinct histopathologic malignancies while simultaneously encoding an etiologic mutation and a therapeutic target. Previously considered a minor mutational event in epithel...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
